Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report
D Jenniches, AF Kerns, J DelBianco… - American Journal of …, 2023 - academic.oup.com
Purpose Apixaban is a direct-acting oral anticoagulant that selectively inhibits factor Xa.
Reversal strategies utilized to treat factor Xa inhibitor–associated bleeding include …
Reversal strategies utilized to treat factor Xa inhibitor–associated bleeding include …
Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report
D Jenniches, AF Kerns, J DelBianco… - … journal of health …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Apixaban is a direct-acting oral anticoagulant that selectively inhibits factor Xa.
Reversal strategies utilized to treat factor Xa inhibitor-associated bleeding include …
Reversal strategies utilized to treat factor Xa inhibitor-associated bleeding include …
Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report.
D Jenniches, AF Kerns, J DelBianco… - American Journal of …, 2023 - europepmc.org
Purpose Apixaban is a direct-acting oral anticoagulant that selectively inhibits factor Xa.
Reversal strategies utilized to treat factor Xa inhibitor-associated bleeding include …
Reversal strategies utilized to treat factor Xa inhibitor-associated bleeding include …
Administration of andexanet alfa for traumatic intracranial hemorrhage in the setting of massive apixaban overdose: A case report
D Jenniches, AF Kerns, J DelBianco… - American Journal of …, 2023 - academic.oup.com
Purpose Apixaban is a direct-acting oral anticoagulant that selectively inhibits factor Xa.
Reversal strategies utilized to treat factor Xa inhibitor–associated bleeding include …
Reversal strategies utilized to treat factor Xa inhibitor–associated bleeding include …